Effect of Insulin Degludec vs Insulin Glargine U100 on Hypoglycemia in Patients With Type 1 Diabetes: The SWITCH 1 Randomized Clinical Trial

IMPORTANCE: Hypoglycemia, common in patients with type 1 diabetes, is a major barrier to achieving good glycemic control. Severe hypoglycemia can lead to coma or death. OBJECTIVE: To determine whether insulin degludec is noninferior or superior to insulin glargine U100 in reducing the rate of sympto...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:JAMA
Glavni autori: Lane, Wendy, Bailey, Timothy S., Gerety, Gregg, Gumprecht, Janusz, Philis-Tsimikas, Athena, Hansen, Charlotte Thim, Nielsen, Thor S. S., Warren, Mark
Format: Artigo
Jezik:Inglês
Izdano: American Medical Association 2017
Teme:
Original Investigation
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5817477/
https://ncbi.nlm.nih.gov/pubmed/28672316
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jama.2017.7115
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items